Clinical Observation of Improved Outcomes of Patients With BRCA 1/2 Breast Cancer Treated With Everolimus Prior to DNA-Damaging Therapy
Year: 2018
Type: article
Source: JCO Precision Oncology
DOI: 10.1200/po.18.00123
Institution: Moffitt Cancer Center
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2888938614
